Athersys (ATHX) Announces CEO Transition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. SPY
6. META
7. BA
8. INTC
9. JBLU
10. HOOD

Go back to Athersys (ATHX) Announces CEO Transition

Athersys Announces CEO Transition

February 16, 2021 7:00 AM EST

Gil Van Bokkelen to Step Down as Chairman and CEO; B.J. Lehmann Appointed Interim CEO

Board Initiating Search for Permanent Successor; Ismail Kola appointed Chairman of the Board

Company Postpones Investor Day

CLEVELAND, Ohio--(BUSINESS WIRE)-- Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® cell therapy, today announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately. The Athersys Board has appointed William (B.J.) Lehmann, the Companys... More